(XRX) Xerox - Ratings and Ratios
Printers, Copiers, Scanners, Software, Services
EPS (Earnings per Share)
Revenue
Dividends
| Dividend Yield | 18.07% |
| Yield on Cost 5y | 2.62% |
| Yield CAGR 5y | 0.00% |
| Payout Consistency | 81.3% |
| Payout Ratio | 94.3% |
| Risk via 5d forecast | |
|---|---|
| Volatility | 74.0% |
| Value at Risk 5%th | 102% |
| Relative Tail Risk | -16.08% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | -1.55 |
| Alpha | -98.43 |
| CAGR/Max DD | -0.48 |
| Character TTM | |
|---|---|
| Hurst Exponent | 0.498 |
| Beta | 1.687 |
| Beta Downside | 1.387 |
| Drawdowns 3y | |
|---|---|
| Max DD | 86.50% |
| Mean DD | 37.88% |
| Median DD | 36.69% |
Description: XRX Xerox December 25, 2025
Xerox Holdings Corp. (NASDAQ:XRX) operates as a global workplace-technology firm, blending hardware, software, and services across North America, Latin America, Europe, the Middle East, Africa, India, and other markets. Its operations are split between the Print & Other segment-covering document systems, multifunction printers, production presses, and the ConnectKey software suite-and Xerox Financial Services (XFS), which provides equipment financing and leasing solutions.
In FY 2024 Xerox reported revenue of roughly $7.2 billion, with the Print & Other segment contributing about 78% and an operating margin that improved to 7.5% versus 5.9% the prior year, driven by higher Managed Print Services (MPS) adoption. The company’s growth is closely tied to macro trends such as corporate digital-transformation spending, remote-work-induced demand for secure document workflow solutions, and the broader shift toward subscription-based services in the technology-hardware sector. Additionally, Xerox’s exposure to financing through XFS adds a low-correlation cash-flow stream that can cushion cyclical swings in equipment sales.
If you want a data-rich, model-backed assessment of XRX’s valuation and risk profile, ValueRay’s analyst notes provide a concise next step for deeper research.
Piotroski VR‑10 (Strict, 0-10) 3.0
| Net Income (-977.0m TTM) > 0 and > 6% of Revenue (6% = 396.4m TTM) |
| FCFTA 0.03 (>2.0%) and ΔFCFTA -2.91pp (YES ≥ +1.0pp, WARN ≥ +0.5pp) |
| NWC/Revenue 5.36% (prev 9.70%; Δ -4.34pp) (YES ≤20% & Δ≤-1pp; WARN ≤25% & Δ≤0 oder ≤40% & Δ≤-3pp) |
| CFO/TA 0.04 (>3.0%) and CFO 410.0m > Net Income -977.0m (YES >=105%, WARN >=100%) |
| Net Debt (3.93b) to EBITDA (89.0m) ratio: 44.12 <= 3.0 (WARN <= 3.5) |
| Current Ratio 1.10 (target 1.5–3.0; WARN 1.2–<1.5 or >3.0–5.0; CFO/TA gate active) |
| Outstanding Shares last Quarter (125.8m) change vs 12m ago 1.16% (target <= -2.0% for YES) |
| Gross Margin 38.47% (prev 32.17%; Δ 6.31pp) >=18% & Δ>=+0.5pp (WARN >=15% & Δ>=0) |
| Asset Turnover 71.85% (prev 76.58%; Δ -4.73pp) >=50% & Δ>=+2pp (WARN >=35% & Δ>=0) |
| Interest Coverage Ratio -1.17 (EBITDA TTM 89.0m / Interest Expense TTM 199.0m) >= 6 (WARN >= 3) |
Altman Z'' 0.79
| (A) 0.04 = (Total Current Assets 3.75b - Total Current Liabilities 3.40b) / Total Assets 10.07b |
| (B) 0.25 = Retained Earnings (Balance) 2.52b / Total Assets 10.07b |
| (C) -0.03 = EBIT TTM -232.0m / Avg Total Assets 9.20b |
| (D) -0.09 = Book Value of Equity -806.0m / Total Liabilities 9.47b |
| Total Rating: 0.79 = (6.56 * A) + (3.26 * B) + (6.72 * C) + (1.05 * D) |
ValueRay F-Score (Strict, 0-100) 35.39
| 1. Piotroski 3.0pt |
| 2. FCF Yield 7.68% |
| 3. FCF Margin 4.93% |
| 4. Debt/Equity 7.61 |
| 5. Debt/Ebitda 44.12 |
| 6. ROIC - WACC (= -4.57)% |
| 7. RoE -87.39% |
| 8. Rev. Trend -37.39% |
| 9. EPS Trend -33.16% |
What is the price of XRX shares?
Over the past week, the price has changed by +0.00%, over one month by -10.43%, over three months by -33.33% and over the past year by -70.19%.
Is XRX a buy, sell or hold?
- Strong Buy: 1
- Buy: 0
- Hold: 2
- Sell: 1
- Strong Sell: 1
What are the forecasts/targets for the XRX price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 3.8 | 50.6% |
| Analysts Target Price | 3.8 | 50.6% |
| ValueRay Target Price | 1.9 | -23.3% |
XRX Fundamental Data Overview December 24, 2025
P/E Forward = 2.6069
P/S = 0.0483
P/B = 0.9208
P/EG = 0.1984
Beta = 1.753
Revenue TTM = 6.61b USD
EBIT TTM = -232.0m USD
EBITDA TTM = 89.0m USD
Long Term Debt = 4.05b USD (from longTermDebt, last quarter)
Short Term Debt = 354.0m USD (from shortTermDebt, last quarter)
Debt = 4.41b USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 3.93b USD (from netDebt column, last quarter)
Enterprise Value = 4.25b USD (318.8m + Debt 4.41b - CCE 479.0m)
Interest Coverage Ratio = -1.17 (Ebit TTM -232.0m / Interest Expense TTM 199.0m)
FCF Yield = 7.68% (FCF TTM 326.0m / Enterprise Value 4.25b)
FCF Margin = 4.93% (FCF TTM 326.0m / Revenue TTM 6.61b)
Net Margin = -14.79% (Net Income TTM -977.0m / Revenue TTM 6.61b)
Gross Margin = 38.47% ((Revenue TTM 6.61b - Cost of Revenue TTM 4.07b) / Revenue TTM)
Gross Margin QoQ = 59.82% (prev 27.98%)
Tobins Q-Ratio = 0.42 (Enterprise Value 4.25b / Total Assets 10.07b)
Interest Expense / Debt = 1.82% (Interest Expense 80.0m / Debt 4.41b)
Taxrate = -153.3% (out of range, set to none) (460.0m / -300.0m)
NOPAT = unknown (EBIT/Op.Income or Taxrate missing)
Current Ratio = 1.10 (Total Current Assets 3.75b / Total Current Liabilities 3.40b)
Debt / Equity = 7.61 (Debt 4.41b / totalStockholderEquity, last quarter 579.0m)
Debt / EBITDA = 44.12 (Net Debt 3.93b / EBITDA 89.0m)
Debt / FCF = 12.05 (Net Debt 3.93b / FCF TTM 326.0m)
Total Stockholder Equity = 1.12b (last 4 quarters mean from totalStockholderEquity)
RoA = -9.70% (Net Income -977.0m / Total Assets 10.07b)
RoE = -87.39% (Net Income TTM -977.0m / Total Stockholder Equity 1.12b)
RoCE = -4.49% (EBIT -232.0m / Capital Employed (Equity 1.12b + L.T.Debt 4.05b))
RoIC = -3.75% (negative operating profit) (EBIT -232.0m / (Assets 10.07b - Curr.Liab 3.40b - Cash 479.0m))
WACC = 0.83% (E(318.8m)/V(4.72b) * Re(12.23%) + (debt cost/tax rate unavailable))
Discount Rate = 12.23% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: 100.0 | Cagr: 1.10%
[DCF Debug] Terminal Value 65.28% ; FCFE base≈400.4m ; Y1≈415.9m ; Y5≈476.2m
Fair Price DCF = 35.71 (DCF Value 4.57b / Shares Outstanding 128.0m; 5y FCF grow 4.06% → 3.0% )
EPS Correlation: -33.16 | EPS CAGR: -13.19% | SUE: 1.56 | # QB: 1
Revenue Correlation: -37.39 | Revenue CAGR: 2.66% | SUE: -1.62 | # QB: 0
EPS next Quarter (2026-03-31): EPS=-0.04 | Chg30d=-0.270 | Revisions Net=+1 | Analysts=3
EPS next Year (2026-12-31): EPS=1.07 | Chg30d=-0.461 | Revisions Net=+0 | Growth EPS=+373.4% | Growth Revenue=+12.1%
Additional Sources for XRX Stock
Tweets: X | Stocktwits
Fund Manager Positions: Dataroma | Stockcircle